Nowadays, 3-D printed objects are ubiquitous, from toys to office supplies to coffee mugs. But new Northeastern faculty member Guohao Dai is pioneering this technology to bring bioengineering solutions to challenges in vascular biology. Specifically, he’s 3-D bioprinting live tissue.
Diomedes Logothetis, the new chair of the Department of Pharmaceutical Sciences, has a vision: To advance Northeastern’s standing as a go-to institution for academic researchers interested in drug discovery. “We can be the engine driving the understanding of how new drugs act,” he says.
New chemical engineering professor Debra Auguste studies human biology at the cellular level with an eye toward identifying more effective drug delivery therapies.
A team led by University Distinguished Professor of Biology Kim Lewis received a five-year, $9 million grant from the National Institute of Health’s National Institute of Allergy and Infectious Diseases to launch a novel platform for developing antibiotics that kill pathogens without encountering resistance.
Throughout Northeastern’s School of Pharmacy, researchers are making progress in solving a range of pressing health challenges.
Chemistry doctoral student Dana Klug makes possible drug options the way a chef makes a gourmet dish—adding an atom of hydrogen here, removing an atom of nitrogen there—to stop a deadly parasite in its tracks.
Northeastern University Distinguished Professor Kim Lewis and his team’s pioneering research presenting a new antibiotic that kills pathogens without encountering any detectable resistance has captured headlines worldwide and drawn widespread praise from the scientific community.
Associate professor of chemistry and chemical biology Michael Pollastri has received a five-year, $2.5 million grant from the National Institutes of Health to advance his research into a treatment for sleeping sickness.
The neglected tropical disease affects tens of thousands of people and is mostly fatal. Now, new research co-authored by Northeastern chemistry professor Michael Pollastri has identified hundreds of chemical compounds that could lead to a cure.
New research from the Center for Drug Discovery at Northeastern presents a series of molecules that can be controllably deactivated, thereby reducing the side effects of potentially valuable drugs.
At the sixth event in Northeastern’s Women Who Inspire series, CEOs of three of the area’s top pharmaceutical companies discussed the challenges and rewards of being a leader in the drug discovery industry.
Fifth-year chemistry major Mark Naniong’s research while on co-op at the Dana-Farber Cancer Institute made it to the pages of a prestigious academic journal—and inspired him to pursue a career linked to innovation in science.